chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: Not eating for quite a few days,Totally out of it; COVID-19; MIssed dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), DECREASED APPETITE (Not eating for quite a few days,Totally out of it) and PRODUCT DOSE OMISSION ISSUE (MIssed dose) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (MIssed dose). On 25-Feb-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced DECREASED APPETITE (Not eating for quite a few days,Totally out of it). At the time of the report, COVID-19 (COVID-19), DECREASED APPETITE (Not eating for quite a few days,Totally out of it) and PRODUCT DOSE OMISSION ISSUE (MIssed dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dehydration, Dizziness, Dyspnoea, Heart rate
Clinical narrative: Really really dizzy, kind of like dehydrated; Really really dizzy, kind of like dehydrated; Having difficulty breathing; Heart rate jumped up at rest; Can barely get out of the car; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure, COPD and Atrial fibrillation.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car). At the time of the report, DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Heart rate: 100 (High) 100 beats at rest.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: updated the outcome of Event(s) from (unknown to Resolved/Recovered)
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Really really dizzy, kind of like dehydrated; Really really dizzy, kind of like dehydrated; Having difficulty breathing; Heart rate jumped up at rest; Can barely get out of the car; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure, COPD and Atrial fibrillation.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car). At the time of the report, DIZZINESS (Really really dizzy, kind of like dehydrated), DEHYDRATION (Really really dizzy, kind of like dehydrated), DYSPNOEA (Having difficulty breathing), HEART RATE INCREASED (Heart rate jumped up at rest) and ASTHENIA (Can barely get out of the car) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Heart rate: 100 (High) 100 beats at rest.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: updated the outcome of Event(s) from (unknown to Resolved/Recovered)
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Malaise, Nervousness, Vaccination site erythema
Clinical narrative: Jittery at injectionsite; Swollen at injection site; Painful again; Red at injection site; Tired; Felt crummy; Itching; Painful; Red at injection site; Woozy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woozy), NERVOUSNESS (Jittery at injectionsite), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (Painful) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DIZZINESS (Woozy), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Painful), the first episode of VACCINATION SITE ERYTHEMA (Red at injection site) and FATIGUE (Tired). On 12-Feb-2021, the patient experienced NERVOUSNESS (Jittery at injectionsite), VACCINATION SITE SWELLING (Swollen at injection site), VACCINATION SITE PAIN (Painful again) and the second episode of VACCINATION SITE ERYTHEMA (Red at injection site). On 10-Feb-2021, DIZZINESS (Woozy), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Painful) and FATIGUE (Tired) had resolved. At the time of the report, NERVOUSNESS (Jittery at injectionsite), VACCINATION SITE SWELLING (Swollen at injection site), VACCINATION SITE PAIN (Painful again) and the last episode of VACCINATION SITE ERYTHEMA (Red at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided by Reporter.  No treatment information provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Jittery at injectionsite; Swollen at injection site; Painful again; Red at injection site; Tired; Felt crummy; Itching; Painful; Red at injection site; Woozy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woozy), NERVOUSNESS (Jittery at injectionsite), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE PAIN (Painful) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DIZZINESS (Woozy), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Painful), the first episode of VACCINATION SITE ERYTHEMA (Red at injection site) and FATIGUE (Tired). On 12-Feb-2021, the patient experienced NERVOUSNESS (Jittery at injectionsite), VACCINATION SITE SWELLING (Swollen at injection site), VACCINATION SITE PAIN (Painful again) and the second episode of VACCINATION SITE ERYTHEMA (Red at injection site). On 10-Feb-2021, DIZZINESS (Woozy), MALAISE (Felt crummy), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE PAIN (Painful) and FATIGUE (Tired) had resolved. At the time of the report, NERVOUSNESS (Jittery at injectionsite), VACCINATION SITE SWELLING (Swollen at injection site), VACCINATION SITE PAIN (Painful again) and the last episode of VACCINATION SITE ERYTHEMA (Red at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided by Reporter.  No treatment information provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itching; Chills; Redness at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Itching) and PAIN IN EXTREMITY (Sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012NM20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills), VACCINATION SITE ERYTHEMA (Redness at injection site) and PAIN IN EXTREMITY (Sore arm). On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching). The patient was treated with ALCOHOL at an unspecified dose and frequency. On 03-Mar-2021, CHILLS (Chills) and PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itching) had not resolved.            Treatment information include application of alcohol pad topically on the affected area Action taken with mRNA-1273 in response to the drug was not applicable.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: exacerbation of asthma; This spontaneous case was reported by a physician and describes the occurrence of ASTHMA (exacerbation of asthma) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 01-Jan-1994, Hypertension since 11-Jan-2002, Osteoporosis since 09-Jan-2017, Drug allergy (Levaquin), Pollen allergy and Allergy (nylon suture material). Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) from 01-Jan-2000 to an unknown date for Allergy, MONTELUKAST from 01-Jan-2000 to an unknown date and FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) from 01-Jan-2018 to an unknown date for Asthma, LISINOPRIL from 01-Jan-2002 to an unknown date for Hypertension, ALENDRONATE SODIUM (ALENDRONATE) from 01-Jan-2018 to an unknown date for Osteoporosis.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHMA (exacerbation of asthma). The patient was treated with PREDNISONE from 02-Feb-2021 to 13-Feb-2021 for Asthma, at a dose of prednisone tapering 40mg down to 5mg. On 15-Feb-2021, ASTHMA (exacerbation of asthma) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: Updated patient demography , relevant history , concomitant medication and the event outcome.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site erythema, Vaccination site pain
Clinical narrative: swollen upper arm area; arm hurts; sore arm; redness around the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen upper arm area), PAIN IN EXTREMITY (arm hurts), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (redness around the injection) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by Reporter.  Concomitant products included LOSARTAN, HYDROCHLOROTHIAZIDE, OXYBUTYNIN and clareton for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen upper arm area), PAIN IN EXTREMITY (arm hurts), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (redness around the injection). At the time of the report, PERIPHERAL SWELLING (swollen upper arm area), PAIN IN EXTREMITY (arm hurts), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (redness around the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided by Reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Arm is still sore; Swollen a little bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still sore) and PERIPHERAL SWELLING (Swollen a little bit) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is still sore) and PERIPHERAL SWELLING (Swollen a little bit). At the time of the report, PAIN IN EXTREMITY (Arm is still sore) and PERIPHERAL SWELLING (Swollen a little bit) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided by Reporter.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Sneezing
Clinical narrative: Sneezing attacks; Cough attacks; Headaches; Fatigue; A spontaneous report was received from a consumer concerning a 73-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headaches, cough attacks, sneezing attacks and fatigue.  The patient's medical history was provided as depression and anxiety. The Concomitant medications reported were Benzonatate, some unknown  antidepressant and antianxiety medication.  On 6 Feb 2021, prior to the onset of the events the patient received dose of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly inan unknown location for prophylaxis of COVID-19 infection.  On 6 Feb 2021, the patient experienced headaches, cough attacks, sneezing attacks, fatigue.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events headaches, cough attacks, sneezing attacks, fatigue was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itchy rash). At the time of the report, RASH PRURITIC (Itchy rash) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications and No Treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: The reporter has stated that she is the patient, not her daughter-in-law. On 12-Jul-2021: Follow-up Information Received on 12 Jul 2021  contains No Significant Information
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Vaccination site mass, Vaccination site rash
Clinical narrative: A red lump and a rash on the injection site; Didn't had any fever, nor anything, just the rash and it's very itchy; Rash on the injection site; A bad rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (A red lump and a rash on the injection site), VACCINATION SITE RASH (Rash on the injection site), RASH PRURITIC (Didn't had any fever, nor anything, just the rash and it's very itchy) and RASH (A bad rash all over the body) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Hypertension and Osteoporosis. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZID for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (A red lump and a rash on the injection site), VACCINATION SITE RASH (Rash on the injection site), RASH PRURITIC (Didn't had any fever, nor anything, just the rash and it's very itchy) and RASH (A bad rash all over the body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (A red lump and a rash on the injection site), VACCINATION SITE RASH (Rash on the injection site), RASH PRURITIC (Didn't had any fever, nor anything, just the rash and it's very itchy) and RASH (A bad rash all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: ADR Form.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Peripheral swelling, Pruritus
Clinical narrative: Itchy; Hot arm; Arm swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), FEELING HOT (Hot arm) and PERIPHERAL SWELLING (Arm swelled up) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PRURITUS (Itchy), FEELING HOT (Hot arm) and PERIPHERAL SWELLING (Arm swelled up). At the time of the report, PRURITUS (Itchy), FEELING HOT (Hot arm) and PERIPHERAL SWELLING (Arm swelled up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided by Reporter.  No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after the Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Side effects after the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling, Oral herpes, Swelling of eyelid
Clinical narrative: Tongue is numb like when eating spicy food; Lips are cold; Lips are swell; Swell on the eye leads; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Tongue is numb like when eating spicy food), ORAL HERPES (Lips are cold), LIP SWELLING (Lips are swell) and SWELLING OF EYELID (Swell on the eye leads) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (Tongue is numb like when eating spicy food), ORAL HERPES (Lips are cold), LIP SWELLING (Lips are swell) and SWELLING OF EYELID (Swell on the eye leads). At the time of the report, HYPOAESTHESIA ORAL (Tongue is numb like when eating spicy food), ORAL HERPES (Lips are cold), LIP SWELLING (Lips are swell) and SWELLING OF EYELID (Swell on the eye leads) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Blood test, Influenza like illness
Clinical narrative: Flu like symptoms; bad reaction; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and ADVERSE REACTION (bad reaction) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 038K20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included STELARA Injections and PREDNISONE for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and ADVERSE REACTION (bad reaction). On 02-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) and ADVERSE REACTION (bad reaction) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Blood test: zero antibodies zero antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Neuralgia, Pain, Rash
Clinical narrative: Nerve pain; Rash on their chest and stomach, that did not last long, and was not itchy nor burning.; The pain was in their back, their hip and down their leg; Very ill; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain), PAIN (The pain was in their back, their hip and down their leg), ILLNESS (Very ill) and RASH (Rash on their chest and stomach, that did not last long, and was not itchy nor burning.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN (The pain was in their back, their hip and down their leg) and ILLNESS (Very ill). On an unknown date, the patient experienced NEURALGIA (Nerve pain) and RASH (Rash on their chest and stomach, that did not last long, and was not itchy nor burning.). At the time of the report, NEURALGIA (Nerve pain), PAIN (The pain was in their back, their hip and down their leg), ILLNESS (Very ill) and RASH (Rash on their chest and stomach, that did not last long, and was not itchy nor burning.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Pruritus, Swelling
Clinical narrative: Swelling; Itchy; Hardness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness). At the time of the report, SWELLING (Swelling), PRURITUS (Itchy) and INJECTION SITE INDURATION (Hardness) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided.  No relevant concomitant medication provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling hot, Pain, Pyrexia
Clinical narrative: Low grade fever 99.7°F; achy; Feels warm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever 99.7°F), PAIN (achy) and FEELING HOT (Feels warm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Low grade fever 99.7°F), PAIN (achy) and FEELING HOT (Feels warm). At the time of the report, PYREXIA (Low grade fever 99.7°F), PAIN (achy) and FEELING HOT (Feels warm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 99.7 99.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is still sore after 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is still sore after 24 hours) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm is still sore after 24 hours). At the time of the report, PAIN IN EXTREMITY (arm is still sore after 24 hours) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant products used was not  provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Her arm was a little sore after the first dose.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Her arm was a little sore after the first dose.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts, Drug allergy, Blood pressure high (Increased medication last couple of years.), High cholesterol (Started medication 6 months ago.) and CPAP (Improving, Very mild). Concomitant products included VALSARTAN and DILTIAZEM for Blood pressure high, ATORVASTATIN for High cholesterol, ESTRADIOL (ESTROGEN), PROGESTERONE, TESTOSTERONE and FLUOXETINE for Menopause.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (Her arm was a little sore after the first dose.). At the time of the report, VACCINATION SITE PAIN (Her arm was a little sore after the first dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-026766 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received and New events added.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Oral mucosal blistering, Peripheral swelling
Clinical narrative: Blister under the tongue; Swelling on the feet; Joint pain; Muscle aches; joint , muscle and head aches; Fever 101.5; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches) and HEADACHE (joint , muscle and head aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches), HEADACHE (joint , muscle and head aches) and PYREXIA (Fever 101.5). At the time of the report, ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches), HEADACHE (joint , muscle and head aches) and PYREXIA (Fever 101.5) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Blister under the tongue; Swelling on the feet; Joint pain; Muscle aches; joint , muscle and head aches; Fever 101.5; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches) and HEADACHE (joint , muscle and head aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches), HEADACHE (joint , muscle and head aches) and PYREXIA (Fever 101.5). At the time of the report, ORAL MUCOSAL BLISTERING (Blister under the tongue), PERIPHERAL SWELLING (Swelling on the feet), ARTHRALGIA (Joint pain), MYALGIA (Muscle aches), HEADACHE (joint , muscle and head aches) and PYREXIA (Fever 101.5) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: itching at the injection site; mild ache at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE PAIN (mild ache at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (mild ache at the injection site). On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE PAIN (mild ache at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Skin discolouration, Vaccination site pain
Clinical narrative: it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash; I saw discoloration on arm; painful arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash), SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, ATENOLOL, AMLODIPINE and UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO ELLIPTA) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm). On 12-Feb-2021, the patient experienced ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash). The patient was treated with PARACETAMOL (TYLENOL) for Pain relief, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash), SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cold sweat, Heart rate increased
Clinical narrative: Fast heartbeat all day; Cold sweats all over chest; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweats all over chest), ASTHENIA (Weakness) and HEART RATE INCREASED (Fast heartbeat all day) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042l20a) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced COLD SWEAT (Cold sweats all over chest) and ASTHENIA (Weakness). On 27-Jan-2021, the patient experienced HEART RATE INCREASED (Fast heartbeat all day). At the time of the report, COLD SWEAT (Cold sweats all over chest), ASTHENIA (Weakness) and HEART RATE INCREASED (Fast heartbeat all day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included blood thinner, blood pressure medication, Parkinson medication and cholesterol medication.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Reporter denied having email address or fax number.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dizziness, Dry mouth, Myalgia
Clinical narrative: felt dizzy; rash; tested positive for covid; dry mouth; fever; chills; body aches; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tested positive for covid, headache, fever, chills, body aches, dry mouth, rash, dizzy.  The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 JAN 2021 Lab report was tested as covid positive   On 24 JAN 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038K2OA) in the right arm for prophylaxis of COVID-19 infection.  On 26 JAN 2021, the patient experienced the events tested positive for covid. On 25 JAN 2021, the patient experienced the events headache, fever, chills, body aches, dry mouth. On 11 FEB 2021, the patient experienced the events rash and dizzy.  Treatment information was provided as patient has taken paracetamol to relieve symptoms.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events  tested positive for covid, headache, fever, chills, body aches, dry mouth, rash, dizzy were considered as UNKNOWN.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, SARS-CoV-2 test positive
Clinical narrative: felt dizzy; rash; tested positive for covid; dry mouth; fever; chills; body aches; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tested positive for covid, headache, fever, chills, body aches, dry mouth, rash, dizzy.  The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 JAN 2021 Lab report was tested as covid positive   On 24 JAN 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038K2OA) in the right arm for prophylaxis of COVID-19 infection.  On 26 JAN 2021, the patient experienced the events tested positive for covid. On 25 JAN 2021, the patient experienced the events headache, fever, chills, body aches, dry mouth. On 11 FEB 2021, the patient experienced the events rash and dizzy.  Treatment information was provided as patient has taken paracetamol to relieve symptoms.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events  tested positive for covid, headache, fever, chills, body aches, dry mouth, rash, dizzy were considered as UNKNOWN.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Myalgia, Pruritus
Clinical narrative: Feeling hot; Itchy; Red line; soreness; Redness; A spontaneous report was received from a healthcare consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Itchy/ Pruritus, Redness/ Erythema, Feeling hot, soreness/ Myalgia, Red line/ Erythema.   The patient's medical history was not provided. Concomitant medications Prednisone, Simvastatin, acetylsalicylic acid (baby aspirin), colecalciferol(vitamin D) used for unknown indication were reported.  On 03-FEB-2021, prior to the onset of events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 10M2OA) via Intramuscular route for prophylaxis of COVID-19 infection.  On 03-FEB-2021, the patient experienced the event(s) Redness/ Erythema, soreness/ Myalgia patient started feeling jittery 24 hours later after receiving 1st dose.On 11-FEB-2021, the patient experienced Itchy/ Pruritus, Red line/ Erythema, Feeling  hot.   No treatment information was provided.The patient did not receive any treatment. Lab details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), patient Itchy/ Pruritus, Redness/ Erythema, Feeling hot, soreness/ Myalgia, Red line/ Erythema was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea
Clinical narrative: Diarrhea; Upset stomach; A spontaneous report was received from a consumer concerning a 49-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, upset stomach and diarrhea.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events, upset stomach and diarrhea.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, upset stomach and diarrhea was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Fatigue, Myalgia
Clinical narrative: nose bleeds; fatigue; chills; achiness; A spontaneous report was received from a consumer concerning a 72-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, achiness, nose bleeds and fatigue.  The patient's medical history was not provided by the reporter. No concomitant medications were not reported.   On 24 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot number: 030M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 25 Feb 2021, the patient experienced chills and achiness.  On 28 Feb 2021, the patient experienced nose bleeds and fatigue.  Lab details was not provided.  Treatment for the events was not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, chills, achiness was recovered. The outcome of the events, nose bleeds and fatigue were unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever; A spontaneous report was received from a consumer concerning a 56-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events low grade fever, fever now at 101 degrees.  The patient's medical history was not provided. Concomitant medications reported were levothyroxine, metformin, insulin for drug use for unknown indication.  On 16 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 042L20A) via unknown route for prophylaxis of COVID-19 infection. On 10 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) via unknown route for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient experienced the event(s) low grade fever. On 12 Feb 2021, the patient experienced the event(s) fever now at 101 degrees.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), low grade fever, fever now at 101 degrees was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Myalgia; Fever; chills; A spontaneous report was received from a healthcare professional concerning a 76-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events myalgia, fever, chills.  The patient's medical history was not provided. No relevant concomitant medications were reported. Reporter(physician) taking care of 2 patients who received moderna covid-19 vaccine and experienced same symptoms. On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, after receiving second dose of vaccine the patient experienced the event Myalgia, Fever, chills.Consumer provides consent for safety to contact for follow up  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events, myalgia, fever, chills were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: patient has had a headache since Monday; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events patient has had a headache since monday and wanted to take tylenol or mortin /headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 08 Feb 2021, approximately 1 day prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 08 Feb 2021, the patient experienced the event(s) patient has had a headache since monday and wanted to take tylenol or mortin.  Treatment details included no  right now.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), patient has had a headache since monday and wanted to take tylenol or mortin was unknown.